3-year Outcomes of Botulinum Toxin versus Strabismus Surgery for the Treatment of Acute Acquired Comitant Esotropia in Children. Journal Abstract

3-year Outcomes of Botulinum Toxin versus Strabismus Surgery for the Treatment of Acute Acquired Comitant Esotropia in Children.

Publication Date: 2025 Jan 02

Full Text Sources

Elsevier Science

ClinicalKey

Authors

Michael T B Nguyen; Crystal S Y Cheung; David G Hunter; Michael J Wan; Ryan Gise

Abstract

OBJECTIVE

Botulinum toxin is an alternative to conventional strabismus surgery for treatment for acute, acquired, comitant esotropia (AACE). Previous studies suggest that the two treatment approaches may be equally effective for 6 months. The purpose of our study was to determine whether botulinum toxin remains as effective as strabismus surgery for 36 months after treatment.

Source

American journal of ophthalmology

Pub Types(s)

Journal Article

Language

English

PubMed ID

39755349